Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The European Union Horizon Europe (with joint funding from UK Research Innovation) has awarded NetZeroAICT Consortium major funding to develop a novel technology with great potentials to promote climate neutral and sustainable healthcare.

NetZeroAICT Consortium at the kick off meeting in Barcelona. © NetZeroAICT
NetZeroAICT Consortium at kick off meeting in Barcelona

This international transdisciplinary Consortium is led by Professor Regent Lee at the Nuffield Department of Surgical Sciences and coordinated by Collective Minds Radiology. He is a UK Research Innovation Future Leaders Fellow and Associate Professor of Vascular Surgery. The Oxford team further includes Professor Vicente Grau, Professor of Engineering Science at the Institute of Biomedical Engineering. Their team developed the pioneering technology (CT Digital ContrastTM) which can make Computerised Tomography (CT) scans safer, faster, more equitable and more sustainable.

This is an exciting development for the department and will build new training and research capacity for AI research, and will change clinical practice in due course. - Professor Freddie Hamdy

The Horizon Europe award funding (total of €6M) will accelerate scientific development, clinical validation and subsequent regulatory approval of CT Digital Contrast. It will harness the comprehensive collective expertise of the 20 partners across academia, healthcare and industry.

In addition to manufacturing AI Software as Medical Devices (AISaMD) that can minimise the climate and environmental impact of clinical imaging (which accounts for ~1% of global greenhouse emissions), the Consortium will develop a reference framework for delivering AISaMDs using a ‘green’ and sustainable pipeline by incorporating green computational architectures and comprehensively examine the social/life cycle impacts of implementing CT Digital ContrastTM.

A key ambition for the Consortium is to establish it trustworthiness among the stakeholders involved in all sectors. There will be a strong focus on impactful patient public involvement and engagement to refine the Consortium activities.

Professor Freddie Hamdy, Head of Department, said: ‘We are delighted of this funding success by one of our prominent PIs in the department who is bringing together many different partnerships, including industry, to make progress in the application of AI for translational research with a focus on CT imaging. This is an exciting development for the department and will build new training and research capacity for AI research, and will change clinical practice in due course.’

The NetZeroAICT Consortium will be working collaboratively with patients, the public and professionals throughout. Please get in contact with the team at your location if you would like to get involved or email hello@netzeroaict.eu if you would like to get involved.

For further information, please see the linked press release by the University of Oxford.

Logos of the NetZeroAIT Consortium members

 

The NetZeroAICT Consortium members are: University of Oxford, Amires, Rhino Health, AZ Sint-Jan, University of Glasgow, Betthera, GZA (GasthuisZusters Antwerpen), Uniwersytecki Szpital Kliniczny, Escher Cloud AI, Pagni, Z-Visie, University of Sydney, Universidage Federal Fluminense, Collective Minds Radiology, CHU de Nice, AiSentia, Unity Insights, Unilabs, University of Leicester, and FMRP-USP Ribeirao Preto.

Similar stories

Catherine Lovegrove wins best presentation at international conference

NDS DPhil student and MRC Clinical Research Training Fellow, Miss Catherine Lovegrove, was awarded 'Best Presentation' in the session 'Stones / Imaging / Upper Tract Disorders 2' at the 2024 BAUS Annual Scientific Meeting, held in Birmingham from 24 to 26 June.